Clinical Trial Transparency, Medicines Access On Agendas Today

Gilead Solvaldi tablet

The World Health Organization today issued a call for disclosure of results from clinical trials for medical products, no matter what the results of the trials were. And a variety of events and publications are addressing medicines access today.

Whistleblowers: Little UN Protection For Exposing Wrongdoing

UN NY

From AP: High-profile whistleblowers have joined forces for the first time in demanding that the United Nations change a global system they say deters its thousands of staffers from exposing crime, corruption and other wrongdoing.

In a letter sent to Secretary-General Ban Ki-moon on Wednesday, nine current and former U.N. workers say current policies offer “little to no measure of real or meaningful protection” from retaliation that can include firing, harassment and intimidation.

TPP’s Copyright Term Benefits US, Burdens Others

US flag flies over world 2 by Svilen Milev

The US got its way. The Trans-Pacific Partnership agreement (TPP) will require all member nations to have a minimum copyright term of life plus 70 years. As a result, Japan, Canada, New Zealand, and three other nations will have to increase the duration of copyright by 20 years. This copyright term extension will benefit powerful interests in the US, but will hurt consumers and creators in six other nations that are part of the TPP.

All WIPO Filings On The Rise, Serving Mainly Developed Economies; Telecoms Increase

China patent

Today, the World Intellectual Property Organization released the 2014 numbers of filings for its systems for patents, trademarks, and industrial designs, which form the basis of the revenue of the UN organisation. Filings under the three systems grew in 2014, with a notable presence of telecom companies in patent filing activity. Except for China, top filers in the three systems are developed countries. Also noted was that so far, the significant increase in internet domain names has only led to a slight rise in new domain dispute cases.

Redesign Of Ebola Treatment Units Draws 1500 Innovations, Including Locally

Structural view of the redesigned Ebola treatment tent

KAMPALA, UGANDA – In light of the persistence of the Ebola outbreak and the demands it has placed on global infection containment resources and processes, the United States government disaster response community recognised an opportunity to use open innovation to make significant strides in advancing the ability to combat Ebola. The results include a local success story.

Are Generics Companies Using Inter Partes Review To Overturn Patent Court Cases?

Macedo graph 1

NEW YORK – Will generics companies use a win under the new inter partes review mechanism in the United States to overturn pharmaceutical patents in court? A top attorney for a pharmaceutical innovator company says they could indeed. Meanwhile, a new analysis of the inter partes review so far shows it may not be as much of a cause for alarm as previously thought.

European Commission Urged To Fix EU Law Before Addressing IPR Protections In Third Countries

European Commission image

Efforts to revamp protection for and enforcement of intellectual property rights in non-EU countries are welcome, but the European Commission should get Europe’s IPR house in order first, a new draft report by the European Parliament International Trade (INTA) Committee says. Meanwhile, internal IPR reform is advancing on several fronts, said the EC, which gave Intellectual Property Watch an update on the various measures.

Trade Outlook In 2015: The Race Of The Mega-Regionals

RCEP negotiators - or will it be them?

For international trade, 2015 will be “a year of work” rather than of finalisation, as Viviane Reding put it. The comment of the former European Commission vice president and Justice Commissioner focussed on the Trade in Services Agreement (TISA), as she is now the European Parliament’s rapporteur for TISA. The services agreement is still sailing under the radar compared to its bigger cousins, the US-EU bilateral Transatlantic Trade and Investment Partnership (TTIP) and the Trans-Pacific Partnership Agreement (TPP). Yet “a year of work” might well describe the 2015 agenda for the mega-regional trade negotiations too. Will any of them get to the finish line? A race is on in which the United States and European Union seem to anxiously look to China’s advance while fighting rising opposition at home.

Global Fund Publishes Terms Of Reference Of Equitable Access Initiative

Global Fund

An initiative spearheaded by the Global Fund for AIDS, Tuberculosis and Malaria to ensure equitable access to medicines in particular in middle-income countries now has a dedicated webpage publishing the terms of reference of the initiative. Also available is the list of high-level participants who attended the first meeting of the initiative held last week.

Why The Request By Least Developed Countries For An Extension Of The Transitional Period For Granting And Enforcing Medicines Patents Needs To Be Supported

Ellen 't Hoen

Ellen ‘t Hoen writes: On 24 February 2015 Bangladesh on behalf of the 34 Least Developed Country members (LDCs) of the World Trade Organization (WTO) submitted a request for an extension of the transitional period under article 66.1 TRIPS with respect to pharmaceutical products until the country is no longer classified as LDC.[1] The original extension, set to expire on 1st January 2016, specifically removes the obligation for LDCs to comply with Section 5 (Patents) and Section 7 (Protection of Undisclosed Information) of Part II of TRIPS, including any obligation to enforce rights under these provisions.

It is a little known fact that since the adoption of the 2001 Doha Declaration on TRIPS and Public Health, LDCs have frequently used the extension in day-to-day procurement of low cost generic medicines, in particular to access medicines needed for the treatment of HIV.